Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRONCHIOLE
2024-512407-39-00Phase 4Completed
- Sponsor
- Region Örebro län
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metoprolol in chronic obstructive pulmonary disease (COPD), sponsored by Region Örebro län. Primary endpoint: Composite endpoint of time to death, COPD exacerbations, and cardiovascular events. Started Jul 2024; status: completed.
02
Drugs
metoprolol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2024-512407-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512407-39-00.